zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakterielle midler til systemisk brug, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..
delepsine 100 mg enterotabletter
orion corporation - natriumvalproat - enterotabletter - 100 mg
delepsine 300 mg enterotabletter
orion corporation - natriumvalproat - enterotabletter - 300 mg
delepsine 500 mg enterotabletter
orion corporation - natriumvalproat - enterotabletter - 500 mg
delepsine 200 mg/ml orale dråber, opløsning
orion corporation - natriumvalproat - orale dråber, opløsning - 200 mg/ml
delepsine 60 mg/ml oral opløsning
orion corporation - natriumvalproat - oral opløsning - 60 mg/ml
delepsine 300 mg suppositorier
orion corporation - natriumvalproat - suppositorier - 300 mg
delepsine retard 300 mg depottabletter
orion corporation - natriumvalproat - depottabletter - 300 mg
delepsine retard 500 mg depottabletter
orion corporation - natriumvalproat - depottabletter - 500 mg
depakine chrono 300 mg depottabletter
orifarm a/s - natriumvalproat, valproinsyre - depottabletter - 300 mg